Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Key Record Dates Identifier: NCT03351478
Brief Title: Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin (SOTA-EMPA)

First Submitted : November 20, 2017
First Submitted that Met QC Criteria : November 20, 2017
First Posted : November 22, 2017

Last Update Submitted that Met QC Criteria : June 5, 2019
Last Update Posted : June 6, 2019